INTERNATIONAL PATENT: EMMYON, INC. FILES APPLICATION FOR "GLP-1 RECEPTOR AGONIST COMBINATIONS AND USE THEREOF FOR INCREASING WEIGHT LOSS WHILE IMPROVING MUSCLE MASS AND STRENGTH"

GENEVA, May 6 -- EMMYON, INC. (2746 Foxwoods Ln SWRochester, Minnesota 55902) filed a patent application (PCT/US2025/051897) for "GLP-1 RECEPTOR AGONIST COMBINATIONS AND USE THEREOF FOR INCREASING WEIGHT LOSS WHILE IMPROVING MUSCLE MASS AND STRENGTH" on Oct 21, 2025. With publication no. WO/2026/090181, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TALLEY, John (6446 Eichelberger St.St. Louis, Missouri 63109)

Abstract: Disclosed are methods of improving weight loss, reducing body weight, reducing body fat mass, reducin...